What is the best management approach for a patient with severe Acute Respiratory Distress Syndrome (ARDS) secondary to drowning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe ARDS Secondary to Drowning

Implement lung-protective ventilation immediately with tidal volumes of 6 mL/kg predicted body weight, plateau pressures <30 cmH2O, and initiate prone positioning for at least 12-16 hours daily if PaO2/FiO2 ratio is <150 mmHg. 1, 2

Immediate Ventilator Settings

Tidal Volume and Pressure Limits

  • Set tidal volume at 6 mL/kg predicted body weight (acceptable range 4-8 mL/kg PBW), calculated as 50 + 0.91 × [height (cm) - 152.4] kg for males and 45.5 + 0.91 × [height (cm) - 152.4] kg for females 3, 2
  • Maintain plateau pressure <30 cmH2O at all times—this is a strong recommendation with high-quality evidence 3, 2
  • Accept permissive hypercapnia (pH >7.20) as a necessary consequence of lung protection rather than increasing tidal volumes 2

PEEP Strategy

  • For severe ARDS (PaO2/FiO2 <150 mmHg), use higher PEEP levels, typically 12-15 cmH2O 1, 2, 4
  • Titrate PEEP upward to maintain adequate oxygenation while monitoring for hemodynamic compromise 3
  • Higher PEEP prevents alveolar collapse and maintains recruitment in drowning-related ARDS where surfactant dysfunction is prominent 2, 5

Prone Positioning: Critical for Severe ARDS

  • Initiate prone positioning within 48 hours if PaO2/FiO2 ratio <150 mmHg 3, 2
  • Maintain prone position for at least 12-16 hours per day—this is a strong recommendation with moderate-quality evidence showing mortality reduction (RR 0.74) 2, 5, 6
  • Repeat daily sessions until oxygenation improves to PaO2/FiO2 >150 mmHg 5, 4
  • Duration matters: trials demonstrating mortality benefit used >12 hours daily, while shorter durations showed no benefit 2

Neuromuscular Blockade

  • For severe ARDS with PaO2/FiO2 <150 mmHg, administer neuromuscular blocking agents (cisatracurium) for up to 48 hours 3, 2
  • Use early in the course of severe ARDS to improve ventilator synchrony and reduce ventilator-induced lung injury 5, 4
  • Administer as intermittent boluses when possible; reserve continuous infusion for persistent ventilator dyssynchrony or when implementing prone positioning 2

Fluid Management

  • Apply a conservative fluid strategy once initial resuscitation is complete and tissue perfusion is adequate 3, 2
  • Target negative fluid balance using the FACTT-lite protocol—this improves ventilator-free days without increasing non-pulmonary organ failures 2, 5
  • This is particularly important in drowning-related ARDS where pulmonary edema is a primary pathophysiologic feature 2

Oxygenation Targets

  • Target SpO2 of 88-95% to avoid hyperoxia while maintaining adequate tissue oxygenation 2, 5
  • Maintain SpO2 no higher than 96% in acute hypoxemic respiratory failure to prevent oxygen toxicity 2
  • Titrate FiO2 downward as tolerated once adequate oxygenation is achieved 1

Corticosteroids

  • Administer systemic corticosteroids to mechanically ventilated patients with ARDS—this represents the most recent high-quality recommendation from the American Thoracic Society 2
  • This is a conditional recommendation with moderate certainty of evidence 2
  • However, avoid high-dose pulse steroids as they do not improve survival and may cause harm 5

Rescue Therapies for Refractory Hypoxemia

Recruitment Maneuvers

  • Consider recruitment maneuvers cautiously in severe ARDS, but do not use routinely or for prolonged periods as these are associated with harm 3, 2

ECMO Consideration

  • For refractory hypoxemia despite optimized ventilation and prone positioning, consider venovenous ECMO at experienced centers 2, 5, 6
  • Specific indications: PaO2/FiO2 <70 mmHg for ≥3 hours or <100 mmHg for ≥6 hours despite optimal management 5
  • ECMO should only be performed at centers with established expertise and protocols 2, 5

Interventions to Avoid

  • Do not use high-frequency oscillatory ventilation—this is strongly recommended against with moderate-quality evidence 3, 2, 6
  • Do not use β-2 agonists for ARDS treatment without bronchospasm 3, 2
  • Do not routinely use pulmonary artery catheters for ARDS management 3, 2
  • Do not prioritize normocapnia over lung-protective ventilation—accept permissive hypercapnia 2

Supportive Care Measures

  • Maintain head of bed elevation at 30-45 degrees to prevent ventilator-associated pneumonia 3, 5
  • Implement daily spontaneous breathing trials once patients show signs of improvement 3, 2
  • Use a weaning protocol for patients who can tolerate weaning 3
  • Provide deep sedation in the first 48 hours, then minimize continuous sedation targeting specific endpoints 2, 5

Critical Pitfalls to Avoid

  • Do not delay prone positioning in severe ARDS—early implementation (within 48 hours) improves outcomes 2, 5
  • Do not use tidal volumes >8 mL/kg PBW even if plateau pressures are acceptable—both parameters must be optimized simultaneously 2, 7
  • Do not apply higher PEEP indiscriminately in mild ARDS or hemodynamically unstable patients—tailor to disease severity 2, 5
  • Do not use excessive tidal volumes to correct hypercapnia—this negates the mortality benefit of lung-protective ventilation 3, 8
  • Do not maintain fluid-positive balance after initial resuscitation—this worsens pulmonary edema and prolongs mechanical ventilation 2, 5

References

Guideline

Ventilator Management for ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Respiratory Distress Syndrome (ARDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Influenza-Associated ARDS with Alveolar Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.